Terry Katz

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

Bart C. Kuenen, Petronella O. Witteveen, Rita Ruijter et al. · Clinical Cancer Research · 2010 · 86 citations · Full text

Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease

P. Lockwood, Joyce C. Johnson, Terry Katz · Veterinary Record · 2003 · 83 citations

Veterinary Research, Education, Antibacterial Treatment +16

A phase I, first in man study of weekly IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid tumors

Celestia S. Higano, E. Y. Yu, Samuel H. Whiting et al. · Journal of Clinical Oncology · 2007 · 81 citations

Immunocytochemical Technique, Immunodeficiencies, Immunology +19

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

Edward S. Kim, Marcus A. Neubauer, Allen Lee Cohn et al. · The Lancet Oncology · 2013 · 68 citations

Platinum-based Therapy, Medicine, Metronomic Therapy +8

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

Andrew H. Ko, Hagop Youssoufian, Jayne Gurtler et al. · Investigational New Drugs · 2011 · 60 citations

First-line Therapy, Pancreatic Cancer, Phase Ii +8